Ex, you doubted damn near everything NWBO/LP has accomplished
What have they accomplished?
For a dev stage bio the goal is to get a drug approved, partnered or a buyout.
LP took control of NWBO 20 years ago. The exact -L that we are talking now was already developed and had various trials already approved to run. Including a P3 and the P2 that morphed into the P3 now trying to be approved.
In the last 10 years they have not recurited a single patient into a trial to prove any of these combo or improved DC theories.
The supposed great white hope of Direct ran a P1 in 2013-15 and has not been seen since.
The only thing NWBO/LP has accomplished is taking the game of playing retail stockholders to a new level. Congrats on your success in that.
Market Data 
Markets 
AI
